IL117515A - Use of steroidal estrogen receptor antagonists in the production of medicaments for controlling male fertility - Google Patents

Use of steroidal estrogen receptor antagonists in the production of medicaments for controlling male fertility

Info

Publication number
IL117515A
IL117515A IL11751596A IL11751596A IL117515A IL 117515 A IL117515 A IL 117515A IL 11751596 A IL11751596 A IL 11751596A IL 11751596 A IL11751596 A IL 11751596A IL 117515 A IL117515 A IL 117515A
Authority
IL
Israel
Prior art keywords
production
receptor antagonists
estrogen receptor
medicaments
male fertility
Prior art date
Application number
IL11751596A
Other languages
English (en)
Other versions
IL117515A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL117515A0 publication Critical patent/IL117515A0/xx
Publication of IL117515A publication Critical patent/IL117515A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Materials For Medical Uses (AREA)
IL11751596A 1995-03-16 1996-03-17 Use of steroidal estrogen receptor antagonists in the production of medicaments for controlling male fertility IL117515A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19510862A DE19510862A1 (de) 1995-03-16 1995-03-16 Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle

Publications (2)

Publication Number Publication Date
IL117515A0 IL117515A0 (en) 1996-07-23
IL117515A true IL117515A (en) 2003-07-31

Family

ID=7757669

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11751596A IL117515A (en) 1995-03-16 1996-03-17 Use of steroidal estrogen receptor antagonists in the production of medicaments for controlling male fertility

Country Status (21)

Country Link
US (1) US20010056086A1 (xx)
EP (1) EP0814803B1 (xx)
JP (1) JPH11501648A (xx)
KR (1) KR19980703057A (xx)
CN (1) CN1151792C (xx)
AT (1) ATE342055T1 (xx)
CA (1) CA2215373A1 (xx)
CZ (1) CZ293771B6 (xx)
DE (2) DE19510862A1 (xx)
DK (1) DK0814803T3 (xx)
ES (1) ES2275273T3 (xx)
HU (1) HUP9900313A3 (xx)
IL (1) IL117515A (xx)
NO (1) NO974256L (xx)
NZ (1) NZ303672A (xx)
PL (1) PL186085B1 (xx)
PT (1) PT814803E (xx)
SK (1) SK284442B6 (xx)
TW (1) TW503106B (xx)
WO (1) WO1996028154A2 (xx)
ZA (1) ZA962176B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE10159217A1 (de) 2001-11-27 2003-06-05 Schering Ag 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
EP2258375A1 (de) 2009-06-04 2010-12-08 Bayer Schering Pharma Aktiengesellschaft 17B-alkyl-17alpha-oxy-estratriene

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3213328A1 (de) * 1982-04-06 1983-10-06 Schering Ag 3,4,17-trioxygenierte 4,9(11)-androstadiene
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5166201A (en) * 1990-11-30 1992-11-24 Merrell Dow Pharmaceuticals Inc. 2β,19-ethylene bridged steroids as aromatase inhibitors
FR2685332A1 (fr) * 1991-12-20 1993-06-25 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.

Also Published As

Publication number Publication date
DE19510862A1 (de) 1996-09-19
IL117515A0 (en) 1996-07-23
WO1996028154A3 (de) 1997-05-01
AU713467B2 (en) 1999-12-02
EP0814803B1 (de) 2006-10-11
MX9707008A (es) 1997-11-29
ATE342055T1 (de) 2006-11-15
ES2275273T3 (es) 2007-06-01
PL186085B1 (pl) 2003-10-31
KR19980703057A (ko) 1998-09-05
CZ285297A3 (en) 1997-12-17
PL322253A1 (en) 1998-01-19
CN1151792C (zh) 2004-06-02
TW503106B (en) 2002-09-21
CA2215373A1 (en) 1996-09-19
DK0814803T3 (da) 2007-02-19
NZ303672A (en) 2000-07-28
NO974256D0 (no) 1997-09-15
HUP9900313A3 (en) 1999-11-29
ZA962176B (en) 1996-07-29
WO1996028154A2 (de) 1996-09-19
AU5004696A (en) 1996-10-02
JPH11501648A (ja) 1999-02-09
US20010056086A1 (en) 2001-12-27
CZ293771B6 (cs) 2004-07-14
DE59611391D1 (de) 2006-11-23
SK123897A3 (en) 1998-02-04
HUP9900313A1 (hu) 1999-06-28
EP0814803A2 (de) 1998-01-07
PT814803E (pt) 2007-02-28
SK284442B6 (sk) 2005-04-01
NO974256L (no) 1997-11-14
CN1178463A (zh) 1998-04-08

Similar Documents

Publication Publication Date Title
MX9704640A (es) Compuesto moduladores de los receptores de los esteroides y metodos para su preparacion.
EP1382597A3 (en) Steroid receptor modulator compounds and methods
UA83620C2 (ru) Замещенные бензоксазолы и их аналоги как эстрогенные агенты
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
AU2561195A (en) Progesterone antagonists for the production of pharmaceutical agents for the treatment of dysfunctional uterine bleeding
BG106391A (en) Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes
AU7496894A (en) Antiglucocorticoid steroids for the treatment of anxiety disorders
TW282459B (xx)
AU6469401A (en) Pharmaceutically active compounds and methods of use
BG105761A (en) Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
HUP0500346A2 (hu) Konjugált ösztrogének alkalmazása ösztrogénpótó terápiában hatásos gyógyszerkészítmények előállítására
BG104038A (en) Use of specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing
IL117515A (en) Use of steroidal estrogen receptor antagonists in the production of medicaments for controlling male fertility
IS2702B (is) Notkun á (11beta, 17beta)-11-(1,3-bensódíoxól-5-ýl)-17-hýdroxý-17-(1-própýnýl)-estra-4,9-díen-3-ón í meðhöndluninni á alvarlegri geðdeyfðartruflun
PT1365768E (pt) Utilização de antagonistas selectivos para er-beta como contraceptivos
TH26878A (th) การใช้แอนติเอสโทรเจนสำหรับควบคุมการสามารถมีลูกได้ในเพศชาย
AU4625299A (en) Use of a pharmaceutical composition containing, in combination, an antagonist of the angiotensin ii AT1, receptors and indomethacin for making a medicine treating chronic glomerulonephritis
AU2002219192A1 (en) Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect
DK1090028T3 (da) Umættede 14,15-cyclopropano-androstaner, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende disse forbindelser
TH26878B (th) การใช้แอนติเอสโทรเจนสำหรับควบคุมการสามารถมีลูกได้ในเพศชาย
RU97117160A (ru) Применение антиэстрогенов для контроля мужской фертильности
AU6921196A (en) 5-ht3 receptor antagonists for dyskinesia

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed